213 related articles for article (PubMed ID: 25919445)
1. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
Logan SL; Carpenter L; Leslie RS; Garrett-Mayer E; Hunt KJ; Charles J; Nicholas JS
J Child Adolesc Psychopharmacol; 2015 May; 25(4):323-36. PubMed ID: 25919445
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
Houghton R; Liu C; Bolognani F
Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic Medications for Low-Income Preschoolers: Long Duration and Psychotropic Medication Polypharmacy.
Lohr WD; Jawad K; Feygin Y; Le J; Creel L; Pasquenza N; Williams PG; Jones VF; Myers J; Davis DW
Psychiatr Serv; 2022 May; 73(5):510-517. PubMed ID: 34470507
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic medication use and polypharmacy in children with autism spectrum disorders.
Spencer D; Marshall J; Post B; Kulakodlu M; Newschaffer C; Dennen T; Azocar F; Jain A
Pediatrics; 2013 Nov; 132(5):833-40. PubMed ID: 24144704
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
Houghton R; Ong RC; Bolognani F
Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
Casseus M; Kim WJ; Horton DB
Autism Res; 2023 Apr; 16(4):855-867. PubMed ID: 36644987
[TBL] [Abstract][Full Text] [Related]
9. Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.
Logan SL; Carpenter L; Leslie RS; Hunt KS; Garrett-Mayer E; Charles J; Nicholas JS
J Autism Dev Disord; 2014 Nov; 44(11):2931-48. PubMed ID: 24929833
[TBL] [Abstract][Full Text] [Related]
10. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
Rast JE; Anderson KA; Roux AM; Shattuck PT
Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.
Schubart JR; Camacho F; Leslie D
Autism; 2014 Aug; 18(6):631-7. PubMed ID: 24165274
[TBL] [Abstract][Full Text] [Related]
12. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Developmental Behavioral Pediatricians Prescribing Psychotropic Medication to Children with Autism Spectrum Disorder: A Study of Three DBPNet Sites.
Jackel C; Shults J; Wiley S; Meinzen-Derr J; Augustyn M; Blum N
J Dev Behav Pediatr; 2017 Oct; 38(8):584-592. PubMed ID: 28816917
[TBL] [Abstract][Full Text] [Related]
14. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.
Girand HL; Litkowiec S; Sohn M
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32487590
[TBL] [Abstract][Full Text] [Related]
15. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
Jobski K; Höfer J; Hoffmann F; Bachmann C
Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CD.
Liu X; Shah V; Kubilis P; Xu D; Bussing R; Winterstein AG
J Atten Disord; 2019 Jan; 23(2):140-148. PubMed ID: 26269095
[TBL] [Abstract][Full Text] [Related]
17. High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network.
Logan SL; Nicholas JS; Carpenter LA; King LB; Garrett-Mayer E; Charles JM
Ann Epidemiol; 2012 Jan; 22(1):1-8. PubMed ID: 22153288
[TBL] [Abstract][Full Text] [Related]
18. School-Based Behavioral Health Service Use and Expenditures for Children With Autism and Children With Other Disorders.
Kang-Yi CD; Locke J; Marcus SC; Hadley TR; Mandell DS
Psychiatr Serv; 2016 Jan; 67(1):101-6. PubMed ID: 26278232
[TBL] [Abstract][Full Text] [Related]
19. Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994-2009.
Kamimura-Nishimura K; Froehlich T; Chirdkiatgumchai V; Adams R; Fredstrom B; Manning P
Ann Epidemiol; 2017 Jul; 27(7):448-453.e1. PubMed ID: 28789776
[TBL] [Abstract][Full Text] [Related]
20. Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.
Kreider AR; Matone M; Bellonci C; dosReis S; Feudtner C; Huang YS; Localio R; Rubin DM
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):960-970.e2. PubMed ID: 25151419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
